<DOC>
	<DOCNO>NCT02746445</DOCNO>
	<brief_summary>The purpose study continue evaluate long-term effectiveness Magnetic EEG/ECG-Guided Resonance Therapy ( MeRT ) child Autism Spectrum Disorder ( ASD ) . No active MeRT treatment perform study .</brief_summary>
	<brief_title>A Longitudinal Study Safety Efficacy Subjects With ASD Who Received MeRT</brief_title>
	<detailed_description>This clinical trial longitudinal study design evaluate safety efficacy subject Autism Spectrum Disorder ( ASD ) receive Magnetic EEG/ECG-Guided Resonance Therapy ( MeRT ) IRB approve clinical trial . A total twenty-eight ( 28 ) subject follow study . After provide informed consent , twenty-eight ( 28 ) subject participate previous protocol observe three ( 3 ) year post-MeRT treatment . During period , subject evaluate 104 156 week post-MeRT treatment .</detailed_description>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>1 . Subject must complete MeRT001 ( formerly know MRT001 ) clinical trial conduct Brain Treatment Center ( BTC ) 2 . Age 6 15 year ( day inform consent ) 3 . Willing able adhere study visit 1 . Subjects participate MeRT001 clinical trial . 2 . Any condition judgment investigator would prevent subject completion study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Autism</keyword>
	<keyword>ASD</keyword>
	<keyword>Autism Spectrum Disorder</keyword>
</DOC>